Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine hospital

被引：0
|
作者：
Arenos, C. C. [1 ]
San Juan, M. [1 ]
Lim, S. [1 ]
Lominoque, A. [1 ]
Reveldez, I. [1 ]
Sison-DImaano, A. [1 ]
Pangandaman, N. [1 ]
Tatoy, V. [1 ]
Uy, T. [1 ]
机构：
[1] Univ Philippines, Div Med Oncol, Dept Med, Philippine Gen Hosp, Manila, Philippines
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P85-2
引用
收藏
页码：S1390 / S1390
页数：1
相关论文
共 50 条
  • [21] HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
    Kurozumi, Sasagu
    Padilla, Mary
    Kurosumi, Masafumi
    Matsumoto, Hiroshi
    Inoue, Kenichi
    Horiguchi, Jun
    Takeyoshi, Izumi
    Oyama, Tetsunari
    Ranger-Moore, Jim
    Allred, D. Craig
    Dennis, Eslie
    Nitta, Hiroaki
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 99 - 111
  • [22] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [23] HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases
    Michel, Anna
    Oppong, Marvin Darkwah
    Rauschenbach, Laurel
    Pierscianek, Daniela
    Dinger, Thiemo F.
    Schmidt, Teresa
    Hense, Joerg
    Poettgen, Christoph
    Kimmig, Rainer
    Ahmadipour, Yahya
    Oezkan, Neriman
    Mueller, Oliver
    Junker, Andreas
    Sure, Ulrich
    Jabbarli, Ramazan
    El Hindy, Nicolai
    WORLD NEUROSURGERY, 2021, 152 : E332 - E343
  • [24] Her2 FISH amplification in ER/PR/Her2 IHC negative breast cancer
    Sahoo, Sunati
    Hwang, Helena
    CANCER RESEARCH, 2015, 75
  • [25] Simultaneous targeting of estrogen receptor and HER2 in breast cancer
    Azim, Hatem A., Jr.
    Piccart, Martine J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1255 - 1263
  • [26] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04): : 535 - 540
  • [27] Hormone receptor status might be a determinant for HER2 loss after HER2-targeted treatment in HER2 positive breast cancer patients
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (05): : 2206 - 2206
  • [28] Characterization and clinical outcomes of low hormonal receptor positive / HER2 negative early breast cancer
    Karnmanee, J.
    Dajsakdipon, T.
    Sripaiboonkij, N.
    Dejthevaporn, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S340 - S340
  • [29] Comparison of EndoPredict and MammaPrint in hormone receptor positive, HER2 negative breast cancer
    Boesl, A.
    Spitzmueller, A.
    Haid, A.
    Jasarevic, Z.
    Baruschke, K.
    Jaeger, S.
    Offner, F.
    BREAST, 2015, 24 : S46 - S47
  • [30] Evaluating the efficacy of neoadjuvant endocrine therapy in HER2 low vs. HER2 negative breast cancer: An NCBD analysis
    Chong, Esther G.
    Guo, Mengni
    Castillo, Dani Ran
    Bazan, Jose G.
    Yap, Kelly Khai Li
    Schultz-Costello, Katharine
    Wu, S. Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345